Paeds SAQs · clinical-pharmacology-and-therapeutics
Weight-based dosing, body-surface area and dose calculation — formative SAQs
Two MedVellum formative short-answer questions on paediatric weight-based dosing, body-surface-area calculation and dose-calculation safety: the Mosteller formula worked at the bedside, the maximum adult-dose cap, the leading-zero and no-trailing-zero rules, the choice of weight scalar in obesity, and the therapeutic drug monitoring loop for vancomycin and gentamicin. The marks and timing support transparent self-assessment. They are not an official board format or pass standard.
On this page
Study tools
Target exams
SAQ 1 — An adolescent requiring a body-surface-area dose
Question 1 — 10 formative marks; suggested time 15 minutes [1]
A 14-year-old girl weighing 52 kg with a height of 160 cm is to start a medicine that is dosed at 50 mg per square metre per dose, with a maximum adult single dose of 90 mg per dose. The formulary states the dose is given once daily. The ward nurse asks you to calculate and write the dose. [1]
- State the formula you will use to estimate the body-surface area, and work the calculation for this child. (3 marks)
- What is the calculated dose in milligrams, and what is the maximum adult single dose cap you must apply? (2 marks)
- State the two writing rules that defend against a tenfold decimal error, and explain why each matters. (3 marks)
- Name the final step in the calculation pathway before the drug is given, and one safeguard that should accompany it. (2 marks) [1]
Full-credit answer — SAQ 1
Reveal full-credit answer for SAQ 1ShowHide
1. Body-surface-area formula and calculation
The bedside formula is the Mosteller formula: body-surface area in square metres equals the square root of the height in centimetres multiplied by the weight in kilograms, divided by 3600. For this child, height 160 cm and weight 52 kg gives 160 times 52 equals 8320, divided by 3600 equals 2.311, and the square root of 2.311 equals 1.52 square metres. [1]
2. Calculated dose and the adult cap
The calculated dose is 1.52 square metres times 50 mg per square metre, which equals 76 mg per dose. The maximum adult single dose stated by the formulary is 90 mg per dose, so the cap does not bind here and the prescribed dose is 76 mg once daily. The cap is checked explicitly, because the principle is that the weight-based or body-surface-area dose never exceeds the adult maximum single or daily dose; in a larger adolescent the cap would bind and the dose would stop at the adult ceiling. [1]
3. The two writing rules
The first rule is the leading zero: write 0.5 mg, never .5 mg, because a bare decimal can be misread as 5 mg and produce a tenfold overdose. The second rule is no trailing zero: write 5 mg, never 5.0 mg, because the trailing zero can be misread as 50 mg and also produce a tenfold overdose. Both rules exist because a misplaced decimal is invisible to the eye and lethal in a small body, and the independent double check is the second defence that catches what the writing rule prevents. [3]
4. Final step and safeguard
The final step before the drug is given is an independent double check by a second clinician, who recalculates the dose, confirms the cap and confirms the units without referring to the original calculation. The accompanying safeguard is to confirm the route, the frequency and the formulation are age-appropriate, and that the concentration of any oral liquid is one calculation assumed. [2] [3]
References6ShowHide
- [1]El Edelbi R, Lindemalm S, Eksborg S Estimation of body surface area in various childhood ages--validation of the Mosteller formula Acta Paediatrica, 2012.PMID 22211780
- [2]Hirata KM, Kang AH, Ramirez GV, et al. Pediatric Weight Errors and Resultant Medication Dosing Errors in the Emergency Department Pediatric Emergency Care, 2019.PMID 28976456
- [3]Lesar TS Tenfold medication dose prescribing errors Annals of Pharmacotherapy, 2002.PMID 12452740
- [4]Procaccini D, Kim JM, Lobner K, et al. Medication Errors in Overweight and Obese Pediatric Patients: A Narrative Review Joint Commission Journal on Quality and Patient Safety, 2022.PMID 35045950
- [7]McNeil JC, Kaplan SL Vancomycin Therapeutic Drug Monitoring in Children: New Recommendations, Similar Challenges Journal of Pediatric Pharmacology and Therapeutics, 2020.PMID 32839650
- [8]Rybak MJ, Le J, Lodise TP, et al. Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists Clinical Infectious Diseases, 2020.PMID 32658968